Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Polymersomes, Carboplatin, and Adebelimab in Resectable Mucosal Melanoma
NCT07336979Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Modality
- Immune Checkpoint Inhibitors, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, adebrelimab in mucosal melanoma (MM), sponsored by Sun Yat-sen University. Started Mar 2025; status: recruiting.
02
Drugs
paclitaxeladebrelimab
03
Conditions
mucosal melanoma (MM)
Beyond the preview
Go deeper on NCT07336979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07336979.